Abbott Laboratories Balance Sheet Health
Financial Health criteria checks 6/6
Abbott Laboratories has a total shareholder equity of $40.0B and total debt of $15.0B, which brings its debt-to-equity ratio to 37.6%. Its total assets and total liabilities are $74.4B and $34.3B respectively. Abbott Laboratories's EBIT is $7.6B making its interest coverage ratio 31.7. It has cash and short-term investments of $7.8B.
Key information
37.6%
Debt to equity ratio
US$15.05b
Debt
| Interest coverage ratio | 31.7x |
| Cash | US$7.79b |
| Equity | US$40.03b |
| Total liabilities | US$34.33b |
| Total assets | US$74.36b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: ABL's short term assets ($23.8B) exceed its short term liabilities ($14.9B).
Long Term Liabilities: ABL's short term assets ($23.8B) exceed its long term liabilities ($19.4B).
Debt to Equity History and Analysis
Debt Level: ABL's net debt to equity ratio (18.1%) is considered satisfactory.
Reducing Debt: ABL's debt to equity ratio has reduced from 59.6% to 37.6% over the past 5 years.
Debt Coverage: ABL's debt is well covered by operating cash flow (58%).
Interest Coverage: ABL's interest payments on its debt are well covered by EBIT (31.7x coverage).